Advertisement
To participate via phone, participants are asked to dial 412-858-4600 afew minutes before 4:30 p.m. ET. The conference call will also be availablevia live web cast on DATATRAK International, Inc.'s web site by clicking thebutton labeled "Click here for Live Web Cast, 1st Quarter Earnings Call" onthe Company's homepage at www.datatrak.net a few minutes before 4:30 p.m. ET.
Advertisement
A replay of the phone call and web cast will each be available atapproximately 6:30 p.m. ET on May 8, 2008 and will run until 9:00 a.m. ET onMay 15, 2008. The phone replay can be accessed by dialing 412-317-0088(access code 419020). To access the web cast replay go to the Company'shomepage at www.datatrak.net and click the button labeled "Click here forReplay of Web Cast, 1st Quarter Earnings Call."
DATATRAK International, Inc. is a worldwide technology company focused onthe provision of multi-component eClinical solutions and related services forthe clinical trials industry. The Company delivers a complete portfolio ofsoftware products that were created in order to accelerate clinical researchdata from investigative sites to clinical trial sponsors and ultimately theFDA, faster and more efficiently than manual methods or loosely integratedtechnologies. The DATATRAK eClinical(TM) software suite can be deployedworldwide through an ASP offering or in a licensed Enterprise Transfer ASPmodel that fully empowers clients to design, set up and manage their clinicaltrials independently. The DATATRAK software suite and its earlier versionshave successfully supported hundreds of international clinical trialsinvolving thousands of clinical research sites and encompassing tens ofthousands of patients in 59 countries. DATATRAK International, Inc.'s productsuite has been utilized in some aspect of the clinical development of 16separate drugs and one medical device that have received regulatory approvalfrom either the United States Food and Drug Administration or counterpartEuropean bodies. DATATRAK International, Inc. has offices located inCleveland, Ohio, Bonn, Germany, and Bryan, Texas. Its common stock is listedon the NASDAQ Stock Market under the ticker symbol "DATA". Visit the DATATRAKInternational, Inc. web site at www.datatrak.net.
Except for the historical information contained in this press release, thestatements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions,estimates and current beliefs concerning the operations, future results andprospects of the Company and are subject to uncertainties and factors(including those specified below) which are difficult to predict and, in manyinstances, are beyond the control of the Company. Factors that may causeactual results to differ materially from those in the forward-lookingstatements include the limited operating history on which the Company'sperformance can be evaluated; the ability of the Company to continue toenhance its software products to meet customer and market needs; fluctuationsin the Company's quarterly results; the viability of the Company's businessstrategy and its early stage of development; the timing of clinical trialsponsor decisions to conduct new clinical trials or cancel or delay ongoingtrials; the Company's dependence on major customers; government regulationassociated with clinical trials and the approval of new drugs; the ability ofthe Company to compete in the emerging EDC market; losses that potentiallycould be incurred from breaches of contracts or loss of customer data; theinability to protect intellec
